AxoGen, Inc. AXGN

AXGN Company Overview

AxoGen, Inc. is a U.S.-based medical technology company focused on the development, manufacture, and commercialization of solutions for peripheral nerve repair and regeneration. The company operates within the medical devices and regenerative medicine industries, serving surgeons and healthcare providers who treat patients with nerve injuries resulting from trauma, surgical procedures, or disease. AxoGen’s offerings are designed to improve clinical outcomes by providing alternatives to autograft nerve repair, which has traditionally required harvesting a patient’s own nerve tissue.

The company’s primary revenue drivers are its biologic and synthetic nerve repair products used in upper and lower extremity procedures. AxoGen is known for its specialized focus on peripheral nerve repair, a niche segment within reconstructive surgery, and for its integrated product portfolio addressing multiple aspects of nerve protection, repair, and regeneration. Founded in 2006, AxoGen evolved from early research in nerve regeneration technologies into a commercial-stage company, completing its initial public offering in 2013 and subsequently expanding its product portfolio and clinical evidence base.